Atara Biotherapeutics (ATRA) Enterprise Value (2014 - 2026)
Atara Biotherapeutics' Enterprise Value was $162.68 million in Q2 2026, up 126.5% from $71.84 million a year earlier and up 179.5% from the prior quarter.
Atara Biotherapeutics (ATRA) Enterprise Value (2014 - 2026) Analysis & Trends
For FY2025, Enterprise Value at Atara Biotherapeutics came in at $218.42 million, up 282.1% from FY2024.
- Enterprise Value shows a five-year compound annual growth rate of -28.1% (FY2020 to FY2025).
- In earlier years, Enterprise Value was $57.17 million in FY2024, $2.86 million in FY2023 (-96.0%), $71.82 million in FY2022 (-93.3%) and $1.07 billion in FY2021 (-5.5%).
- Quarterly Enterprise Value has moved between -$6.49 million (Q3 2024) and $1.22 billion (Q3 2021) over five years.
- Compared with a year earlier, Enterprise Value has increased for three straight quarters, with growth averaging 156.7% over the last five quarters.
- The best year-over-year quarter for Enterprise Value over five years was Q2 2025 (growth of 324.5%); the worst was Q2 2023 (a decline of 97.7%).
- Per Business Quant data, ATRA's Enterprise Value in the three quarters before Q2 2026 was $58.2 million (Q1 2026), $218.42 million (Q4 2025) and $180.66 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | Atara Biotherapeutics | 141.16 Mn | 131.26 Mn | 439,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 162.68 Mn |
| Mar 31, 2026 | 58.20 Mn |
| Dec 31, 2025 | 218.42 Mn |
| Sep 30, 2025 | 180.66 Mn |
| Jun 30, 2025 | 71.84 Mn |
| Mar 31, 2025 | 50.10 Mn |
| Dec 31, 2024 | 57.17 Mn |
| Sep 30, 2024 | -6.49 Mn |
| Jun 30, 2024 | 16.92 Mn |
| Mar 31, 2024 | 37.27 Mn |
| Dec 31, 2023 | 2.86 Mn |
| Sep 30, 2023 | 48.44 Mn |
| Jun 30, 2023 | 9.13 Mn |
| Mar 31, 2023 | 74.55 Mn |
| Dec 31, 2022 | 71.82 Mn |
| Sep 30, 2022 | 93.24 Mn |
| Jun 30, 2022 | 403.72 Mn |
| Mar 31, 2022 | 565.93 Mn |
| Dec 31, 2021 | 1.07 Bn |
| Sep 30, 2021 | 1.22 Bn |
Atara Biotherapeutics Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=ATRA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "ATRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=ATRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();